Lung Institute Dallas

The Lung Health Institute was a medical provider specializing in regenerative medicine for chronic lung diseases, with a significant clinic location in Dallas, Texas. The facility primarily offered autologous stem cell therapies, which involved using a patient's own blood or bone marrow-derived cells to treat conditions such as COPD, pulmonary fibrosis, and emphysema. While the institute operated commercially for several years, it faced significant scrutiny from the medical community and regulatory bodies for marketing unproven treatments. The Dallas clinic, along with the rest of the network, eventually ceased operations following legal challenges and increased regulatory oversight of the direct-to-consumer stem cell industry.